F
Generex Biotechnology Corporation GNBTQ
OTC PK
Recommendation
--
Prev Close
$0.000001
Volume
--
Avg Vol (90D)
0
Market Cap
--
Dividend & Yield
--
52-Week Range
$0.00 - $0.00
P/E (TTM)
0.00
EPS (TTM)
-$0.5203
My Lists My Alerts
Rating
Reward
--
--
Risk
--
--
Rating Factors
Growth Index
--
Efficiency Index
--
Solvency Index
--
Total Return Index
--
Volatility Index
--
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$692.70K
EBITDA (TTM)
-$33.30M
EBIT (TTM)
-$34.31M
Net Income (TTM)
-$37.26M
Balance Sheet
Total Assets (Q)
$45.92M
Total Debt (Q)
$10.60M
Total Liabilities (Q)
$90.01M
Book Value Per Share (Q)
-$0.4845
Cash Flow
Cash from Operations (TTM)
-$2.37M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$3.64M
Net Change in Cash (TTM)
$1.26M
Filings
Filing Date
Monday, June 21, 2021
Period Date
Wednesday, March 31, 2021
Next Filing
(est)
Price History
Loading...
Beta
69.22
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
-99.00%
3-Year Total Return
-100.00%
5-Year Total Return
-100.00%
52-week Low
Nov 20, 2024 - $0.00
52-week High
Nov 20, 2024 - $0.00
Valuation
Market Cap
-- - --
Enterprise Value
--
Price/Sales (TTM)
0.00
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
140.41M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
generex.com/index.html
Phone Number
416 364 2551
Address
10102 USA Today Way
Miramar, FL 33025
Country
United States
Year Founded
1983
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in... more
Weiss Ratings